ENTITY

Argenx SE (ARGX US)

44
Analysis
Health CareNetherlands
argenx SE operates as a biotechnology company. The Company develops antibody based therapies for the treatment of severe autoimmune diseases and cancer. argenx serves customers in the Netherlands and Belgium.
more
bullishImmunovant Inc
25 May 2021 21:46

MergerTalk: Why Skepticism Over A Potential Immunovant Buyout May Offer A Lucrative Opportunity

Why we think it  is more likely than not that minority shareholders of  Immunovant (IMVT US) will receive a buyout proposal with a hefty premium...

Logo
343 Views
Share
bullishMSCI ACWI Index
25 Jun 2020 21:37

Global Equity Strategy: Stick With Technology

Global indexes remain overwhelmingly positive which is supported by the fact that there is a dearth of breakdowns. Overall our big picture view...

Logo
372 Views
Share
x